| AR | Androgen receptor |
| BC | Breast cancer |
| BRCA1 | Breast cancer type 1 susceptibility gene |
| CK 5/6 | Cytokeratin 5/6 |
| DC | Dendritic cells |
| DNA | Deoxyribonucleic acid |
| EGFR | Epidermal growth factor receptor |
| ER | Estrogen receptor |
| FOXA1 | Forkhead box protein A1 |
| HES | Hematoxylin-Eosin-Saffron |
| HER2 | Human epidermal growth factor receptor 2 |
| HR | Hazard ratio |
| IHC | Immunohistochemistry |
| NK | Natural killer |
| OS | Overall survival |
| PCR | Polymerase chain reaction |
| PD-1 | Programmed cell death 1 |
| PD-L1 | Programmed cell death ligand 1 |
| PR | Progesterone receptor |
| REMARK | Reporting recommendations for tumor marker prognostic studies |
| RFS | Relapse-free survival |
| SC | Stromal cells |
| TC | Tumor cells |
| TCR | T cell receptor |
| TIL | Tumor infiltrating lymphocyte |
| TMA | Tissue microarray |
| TNBC | Triple-negative breast cancer |